Alliance for Human Research Protection (AHRP) reports that Former FDA Commissioner Dr. Margaret Hamburg is being charged with “conspiracy… to reap large financial returns by failing to disclose… the full extent of the devastating, life-threatening, and deadly effects of a highly dangerous pharmaceutical drug named Levaquin.” This is a very serious allegation in its own right. There is more.
“The suit alleges that Dr. Hamburg and her husband had made large donations to Hillary Clinton’s campaigns, and to the Clinton Foundation… Defendant Hamburg was recommended to and promoted to President Obama to fill the role of FDA Commissioner by Hillary Clinton, to whom Defendant Hamburg and Defendant Brown had provided, and continue to provide, significant political contributions and other gratuities. ($2 million contribution to Hillary Clinton election campaign, according to OpenSecrets.org).”
A Federal Lawsuit charges Dr. Margaret Hamburg, former Commissioner of the Food and Drug Administration (FDA) with conspiracy, racketeering & colluding to conceal deadly drug dangers – under the federal Racketeer Influenced and Corrupt Organizations law (RICO) law. The amended RICO lawsuit was filed on April 11, 2016 in the U.S. District Court in Washington D.C. on behalf of eight plaintiffs who claim they have suffered severe harm by ingesting the drug, Levaquin whose deadly risks were concealed to protect financial interests.
— Alliance for Human Research Protection
You may read the entire amended legal complaint:
This Amended Complaint sets forth allegations that involve a conspiracy by Defendants, each and every one of them, to reap large financial returns by failing to disclose to Plaintiffs and the public at large the full extent of the devastating, life-threatening, and deadly effects of a highly dangerous pharmaceutical drug named Levaquin. Specifically, on or about May of 2009, President Barack Obama nominated Dr. Margaret A. Hamburg as a political appointee to become Commissioner of the U.S. Food and Drug Administration (FDA). On information and belief, Dr. Margaret A. Hamburg was nominated as a result of huge political and other gratuities to Hillary Clinton and The Clinton Foundation, and at Mrs. Clinton’s recommendation. During the confirmation process before Congress, Dr. Margaret A. Hamburg, acting in concert with her husband, Peter F. Brown and the other Defendants named in this Amended Complaint, at all material times the Co-CEO of a hedge fund named Renaissance Technologies, L.L.C., failed to disclose to Congress and other relevant authorities, her and her husband’s clear-cut conflict of interest – specifically, that Renaissance Technologies, L.L.C. held hundreds of millions of dollars of Johnson & Johnson stock, the manufacturer of the deadly drug, Levaquin.
I thank fellow-blogger, Honey, at Slices of Heaven in Sweden for bringing this news story to my attention. In her introduction to the news link she posted, she says, “It amazes me that USA citizens are uninformed and not demanding actions. I hope that EU evaluates these drugs independently before they approve them for use in Europe.”
Honey has a point about U.S. citizens being uninformed. By Googling “Margaret A. Hamburg lawsuit,” I saw this story has little coverage by the American mainstream media. Some major news network affiliates did appear to cover it on local stations. That’s about it. For example ABC2, or WMAR Baltimore, covered the initial lawsuit on January 20, 2016. Presumably, they thought it was news-worthy because a local Baltimore woman is one of the plaintiffs.
On the other hand, both The New York Times and Time, for instance, reported on Hamburg’s resignation from the FDA in March of 2016. This coverage praised her FDA tenure, particularly for quickening the pace of drug approvals. The search terms “Margaret Hamburg” and “Levaquin lawsuit” found nothing at either NYTimes or Time about the lawsuit.
The original Levaquin Complaint is dated January 18, 2016. The lawsuit’s amendment of April 11, 2016 adds the aspect of political conspiracy to the complaint.